145 related articles for article (PubMed ID: 7905838)
1. Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor.
Rasmussen LK; Sørensen ES; Petersen TE; Gliemann J; Jensen PH
FEBS Lett; 1994 Jan; 338(2):161-6. PubMed ID: 7905838
[TBL] [Abstract][Full Text] [Related]
2. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase.
Ikura K; Takahata K; Sasaki R
FEBS Lett; 1993 Jul; 326(1-3):109-11. PubMed ID: 8100780
[TBL] [Abstract][Full Text] [Related]
3. Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide.
Jensen PH; Sørensen ES; Petersen TE; Gliemann J; Rasmussen LK
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):91-4. PubMed ID: 7646476
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide.
Dudek SM; Johnson GV
Brain Res; 1994 Jul; 651(1-2):129-33. PubMed ID: 7922559
[TBL] [Abstract][Full Text] [Related]
5. Beta-endorphin modification by transglutaminase in vitro: identification by FAB/MS of glutamine-11 and lysine-29 as acyl donor and acceptor sites.
Pucci P; Malorni A; Marino G; Metafora S; Esposito C; Porta R
Biochem Biophys Res Commun; 1988 Jul; 154(2):735-40. PubMed ID: 2900006
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques.
Zhang W; Johnson BR; Suri DE; Martinez J; Bjornsson TD
Acta Neuropathol; 1998 Oct; 96(4):395-400. PubMed ID: 9797004
[TBL] [Abstract][Full Text] [Related]
7. [Alzheimer disease. Role of beta A4 peptide and cerebral amyloid substance].
Duyckaerts C; Delaère P; He Y; Seilhean D; Hauw JJ
Presse Med; 1994 May; 23(18):848-54. PubMed ID: 7937606
[TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
9. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
Otvos L; Szendrei GI; Lee VM; Mantsch HH
Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
[TBL] [Abstract][Full Text] [Related]
10. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.
Maggio JE; Stimson ER; Ghilardi JR; Allen CJ; Dahl CE; Whitcomb DC; Vigna SR; Vinters HV; Labenski ME; Mantyh PW
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5462-6. PubMed ID: 1608956
[TBL] [Abstract][Full Text] [Related]
11. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick D; Soreghan B; Kwon M; Kosmoski J; Knauer M; Henschen A; Yates J; Cotman C; Glabe C
J Biol Chem; 1992 Jan; 267(1):546-54. PubMed ID: 1730616
[TBL] [Abstract][Full Text] [Related]
12. Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase.
Mehul B; Bawumia S; Hughes RC
FEBS Lett; 1995 Feb; 360(2):160-4. PubMed ID: 7875321
[TBL] [Abstract][Full Text] [Related]
13. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.
Kahlem P; Terré C; Green H; Djian P
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14580-5. PubMed ID: 8962095
[TBL] [Abstract][Full Text] [Related]
14. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.
Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
J Mol Biol; 1992 Nov; 228(2):460-73. PubMed ID: 1453457
[TBL] [Abstract][Full Text] [Related]
15. A beta A4 amyloid precursor protein gene and Alzheimer's disease.
Hendriks L; Van Broeckhoven C
Eur J Biochem; 1996 Apr; 237(1):6-15. PubMed ID: 8620894
[TBL] [Abstract][Full Text] [Related]
16. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
Achyuthan KE; Dobson JV; Greenberg CS
Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
[TBL] [Abstract][Full Text] [Related]
17. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
Buée L; Ding W; Delacourte A; Fillit H
Brain Res; 1993 Jan; 601(1-2):154-63. PubMed ID: 8431762
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of the Alzheimer's amyloid beta-peptide.
Soto C; Brañes MC; Alvarez J; Inestrosa NC
J Neurochem; 1994 Oct; 63(4):1191-8. PubMed ID: 7931272
[TBL] [Abstract][Full Text] [Related]
19. Identification of the epsilon-(gamma-glutamyl)lysine cross-linking sites in alpha-lactalbumin polymerized by mammalian and microbial transglutaminases.
Lee DS; Matsumoto S; Matsumura Y; Mori T
J Agric Food Chem; 2002 Dec; 50(25):7412-9. PubMed ID: 12452668
[TBL] [Abstract][Full Text] [Related]
20. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
